Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-24-000160
Filing Date
2024-11-05
Accepted
2024-11-05 16:02:44
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20240930.htm   iXBRL 10-Q 873894
2 EX-10.1 exhibit101fourthamendmentt.htm EX-10.1 26092
3 EX-10.2 exhibit102secondletteragre.htm EX-10.2 32604
4 EX-31.1 exhibit31-1q32024.htm EX-31.1 9097
5 EX-31.2 exhibit31-2q32024.htm EX-31.2 9074
6 EX-32.1 exhibit32-1q32024.htm EX-32.1 4002
7 EX-32.2 exhibit32-2q32024.htm EX-32.2 3837
  Complete submission text file 0001125345-24-000160.txt   5099621

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20240930.xsd EX-101.SCH 32446
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20240930_cal.xml EX-101.CAL 46407
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20240930_def.xml EX-101.DEF 188776
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20240930_lab.xml EX-101.LAB 505525
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20240930_pre.xml EX-101.PRE 349280
63 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20240930_htm.xml XML 588933
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 241427363
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)